Lista de obras - Signe Regner Michaelsen - Dominio Público Uruguay

18F-FET microPET and microMRI for anti-VEGF and anti-PlGF response assessment in an orthotopic murine model of human glioblastoma

artículo científico publicado en 2015

Assessment of Quantitative and Allelic MGMT Methylation Patterns as a Prognostic Marker in Glioblastoma

artículo científico publicado en 2016

Biomarkers in Recurrent Grade III Glioma Patients Treated with Bevacizumab and Irinotecan.

artículo científico publicado en 2018

Cell-free DNA in newly diagnosed patients with glioblastoma - a clinical prospective feasibility study

scientific article published on 08 July 2019

Clinical variables serve as prognostic factors in a model for survival from glioblastoma multiforme: an observational study of a cohort of consecutive non-selected patients from a single institution.

artículo científico publicado en 2013

Combined EGFR- and notch inhibition display additive inhibitory effect on glioblastoma cell viability and glioblastoma-induced endothelial cell sprouting in vitro.

artículo científico publicado en 2016

Comparison of (18)F-FET and (18)F-FLT small animal PET for the assessment of anti-VEGF treatment response in an orthotopic model of glioblastoma

artículo científico publicado en 2015

DNA Methylation Levels of the ELMO Gene Promoter CpG Islands in Human Glioblastomas.

artículo científico publicado en 2018

Development and validation of a prognostic model for recurrent glioblastoma patients treated with bevacizumab and irinotecan

artículo científico publicado en 2016

Inhibition of histone deacetylases sensitizes glioblastoma cells to lomustine.

artículo científico publicado en 2016

Molecular profiling of short-term and long-term surviving patients identifies CD34 mRNA level as prognostic for glioblastoma survival.

artículo científico publicado en 2018

Single agent- and combination treatment with two targeted suicide gene therapy systems is effective in chemoresistant small cell lung cancer cells.

artículo científico publicado en 2012

Targeting glioma stem-like cell survival and chemo-resistance through inhibition of lysine-specific histone demethylase KDM2B.

artículo científico publicado en 2018

Targeting transcriptional addictions in small cell lung cancer with a covalent CDK7 inhibitor

artículo científico publicado en 2014

The impact of bevacizumab treatment on survival and quality of life in newly diagnosed glioblastoma patients

artículo científico publicado en 2014

The use of longitudinal 18F-FET MicroPET imaging to evaluate response to irinotecan in orthotopic human glioblastoma multiforme xenografts

artículo científico publicado en 2014

Transcriptional changes induced by bevacizumab combination therapy in responding and non-responding recurrent glioblastoma patients

artículo científico publicado en 2017

Urokinase-Type Plasminogen Activator Receptor as a Potential PET Biomarker in Glioblastoma

artículo científico publicado en 2015

VEGF-C as a putative therapeutic target in cancer

scientific article published on 18 June 2019

Lista de obras de Signe Regner Michaelsen

18F-FET microPET and microMRI for anti-VEGF and anti-PlGF response assessment in an orthotopic murine model of human glioblastoma

Assessment of Quantitative and Allelic MGMT Methylation Patterns as a Prognostic Marker in Glioblastoma

Biomarkers in Recurrent Grade III Glioma Patients Treated with Bevacizumab and Irinotecan.

Cell-free DNA in newly diagnosed patients with glioblastoma - a clinical prospective feasibility study

Clinical variables serve as prognostic factors in a model for survival from glioblastoma multiforme: an observational study of a cohort of consecutive non-selected patients from a single institution.

Combined EGFR- and notch inhibition display additive inhibitory effect on glioblastoma cell viability and glioblastoma-induced endothelial cell sprouting in vitro.

Comparison of (18)F-FET and (18)F-FLT small animal PET for the assessment of anti-VEGF treatment response in an orthotopic model of glioblastoma

DNA Methylation Levels of the ELMO Gene Promoter CpG Islands in Human Glioblastomas.

Development and validation of a prognostic model for recurrent glioblastoma patients treated with bevacizumab and irinotecan

Inhibition of histone deacetylases sensitizes glioblastoma cells to lomustine.

Molecular profiling of short-term and long-term surviving patients identifies CD34 mRNA level as prognostic for glioblastoma survival.

Single agent- and combination treatment with two targeted suicide gene therapy systems is effective in chemoresistant small cell lung cancer cells.

Targeting glioma stem-like cell survival and chemo-resistance through inhibition of lysine-specific histone demethylase KDM2B.

Targeting transcriptional addictions in small cell lung cancer with a covalent CDK7 inhibitor

The impact of bevacizumab treatment on survival and quality of life in newly diagnosed glioblastoma patients

The use of longitudinal 18F-FET MicroPET imaging to evaluate response to irinotecan in orthotopic human glioblastoma multiforme xenografts

Transcriptional changes induced by bevacizumab combination therapy in responding and non-responding recurrent glioblastoma patients

Urokinase-Type Plasminogen Activator Receptor as a Potential PET Biomarker in Glioblastoma

VEGF-C as a putative therapeutic target in cancer